Matches 1 - 31 out of 31


Match Document Document Title
DE102016225419A1 Olfactory signaling after overheating in technical facilities by pyrolysis of fragrance derivatives  
The present invention relates to a method for providing a technical device with a warning signal against heating and a kit with which the method can be carried out.
DE19730408B4 Composition for topical application  
composition for external use with at least one particulate material selected is selected from the group (A) of the ellagic acid-based compound of the general formula (I): where R1. R2, R3 and R4...
DE19811540B4 Apicularen A, processes for its preparation and cytostatic agent with apicularen A  
apicularen A of formula
DE4323567B4 Aucubin for treating a hepatitis B virus infection  
use of Aucubin, the aglycone of Aucubin or a pharmaceutically acceptable salt or the aglycone of aucubin of aucubin for treating a hepatitis B virus infection.
DE102005013380A1 extraction process  
The This invention relates to a process for the preparation of Tiliroside or Tiliroside-containing extracts from parts of a plant, selected from the family Sterculiaceae, corresponding extracts...
DE102004061145A1 New glucopyranosyl-substituted benzene derivatives are sodium-dependent glucose cotransporter inhibitors, useful for treating e.g. metabolic disorders (type 1 and type 2 diabetes mellitus or metabolic acidosis)  
Glucopyranosyl-substituted benzene derivatives (I) and their tautomers, sterioisomers andsalts are new. Glucopyranosyl-substituted benzene derivatives of formula (I) and their tautomers,...
DE19603788B4 Active extract of devil's claw root, these containing human or veterinary medicinal preparation, method for producing a highly concentrated extract of Radix Harpagophyti or Herba and Radix Scrophularia and also its use  
drug extract of devil's claw root, available by a method in which a crude aqueous extract of Radix Harpagophyti is brought into contact with a non-ionic adsorbent resin and active substances...
DE102004017793A1 Use of trioxacarcins for treatment and prevention of infectious diseases, also new trioxacarcins for treatment of e.g. tumors, inflammatory and autoimmune diseases  
Use of trioxacarcins (I), or their stereoisomers, tautomers and salts, for preparing a composition for treatment and prevention of infectious diseases caused by fungi, parasites, viruses and...
DE10204000A1 Sialysed carbohydrates  
The invention relates to the use of sialic carbohydrates of general formula (I), containing at least one carbohydrate unit of general formula (II) for the immune modulation, immune suppression and...
DE10019235A1 New flavone glycoside derivatives for use in cosmetics, pharmaceuticals and nutrition  
The invention relates to flavone and isoflavone glycoside derivatives of general formula (I): [A1-C(=O)O]m-[X-O-Z]-[O-C(=O)-A2]n (I), wherein [X-O-Z] represents a flavone or isoflavone glycoside...
DE19811540A1 New dioxa-bicyclic compounds apicularene A and B, prepared by culturing new Chondromyces robustus strain, used as cytostatic agent  
The dioxa-tricyclic compounds apicularene A (I) and apicularene B (II) are new. Apicularene A of formula (I) and apicularene B of formula (II) are new. The compounds are also claimed in terms of...
DE19755562A1 Using nitroethane derivatives as microbicides and certain nitroethane derivatives  
The invention relates to the use of nitroethane derivatives of formula (I), wherein the substituents have the following meaning: R<1> = hydrogen, optionally substituted C1-C16 alkyl, C3-C6...
DE19742025A1 Use of flavone or flavanone derivatives to treat or prevent undesirable skin pigmentation  
The use of cosmetically or pharmaceutically acceptable flavone or flavanone derivatives (especially flavonoids) to combat undesirable pigmentation of the skin is claimed.- MECHANISM OF ACTION -...
DE19730408A1 Composition, useful for treatment of cosmetic skin problems e.g. skin pigmentation  
A composition (III) comprises finely divided particles of compounds of formula (I) or its alkali metal salts, where R<1>-R<4> = 1-20C alkyl or acyl; polyoxyalkylene of formula ((CH2)mO)n or a...
DE19603788A1 Preparation of concentrated plant extract, particularly from Harpagophytum procumbens  
Preparation of a highly concentrated plant extract (in particular from devil's claw or Harpagophytum procumbens) comprises: (a) stirring an aqueous crude extract with a non-ionic adsorbent resin;...
DE19512484A1 Carbohydrate-modified cytostatics  
The invention relates to cytostatics which are made tumour-specific by modification with sugar. Suitable spacers ensure serum-stability and intracellular effect at the same time.
DE19509729A1 17-difluoromethylene Estratrienes  
The invention concerns novel 17-difluoromethylene-oestratrienes of general formula (I), in which: R<1> is a hydrogen atom or a C1-C10 alkyl group; R<5> is a methyl or ethyl group; R<2> is a...
DE4430005A1 New malonic acid derivs. of sugars or linear poly:ol  
Malonic acid derivs. of formula (I) are new. R1-R3 = H, (CH2)mX or CH2O(CH2)mX1, or R1+R2 = 6-membered carbocycle or heterocycle substd. by at least one of R4, R5 and R6; A, B = O, S, NH, NHCO,...
DE4323567A1 Hepatitis B viral infection treatment compsn. - contg. iridoid glycoside or aglycone, e.g. aucubin as low toxicity viral DNA replication inhibitor  
Pharmaceutical compsn. for treating hepatitis B virus (HBV) infections in humans and animals contains (apart from conventional carriers, diluents and additives) an iridoid glycoside or corresp....
DE4119472A1 METHOD FOR PRODUCING STEREOSELECTIVE GAL (ALPHA) (1-3) / GAL (BETA) (1-4) / GlcNAc trisaccharides AND NEW (BETA) (1-3) -linked OLIGOLACTOSAMINEN ON NEW PARTIALLY alkylated glycals  
The invention relates to a novel process for the stereoselective preparation of Gal-α (1-3) / Gal-β (1-4) / GlcNac trisaccharides of the formula $ F1 and of β (1-3) -linked oligolactosamines of...
DE4019024A1 USING THE efomycins A, E AND G AS INFLAMMATORY AGENTS  
The present invention relates to the use of the known natural substances Efomycin A, E and G of the general formula $ F1 in which R ↓ 1 ↓ and R ↓ 2 ↓ have the meaning given in the description for...
DE3935016A1 Glycosyl ETOPOSIDE-PRODRUGS, PROCESS FOR PREPARING THEM AND THEIR USE IN COMBINATION WITH functionalized TUMOR SPECIFIC ENZYME CONJUGATES  
The present invention relates to glycosyl-etoposide prodrugs, Process for their preparation and their use in combination with functionalized tumor-specific enzyme conjugates for the treatment of...
DE3913326A1 METHOD FOR PRODUCING ETOPOSIDEN  
The invention relates to a process for the preparation of a beta-glucopyranose derivative of the formula I $ F1 in which $ AR ↑ 1 ↑ and R ↑ 2 ↑ H or an acyl protective group and $ AR ↑ 3 ↑ H,...
DE3913327A1 METHOD FOR PRODUCING glucosaminyl EPI PODO-PHYLLOTOXIN DERIVATIVES  
The invention relates to a novel process for the preparation of glucosaminyl-epi-podophyllotoxin derivatives of the formula I $ F1 in which $ AR ↑ 1 ↑ denotes hydrogen or the acetyl or a mono-,...
DE3833180A1 Enolether OF ELAIOPHYLINS, PROCESS FOR THEIR PRODUCTION, AGENTS CONTAINING THEM AND THEIR USE  
Enol ethers of elaiophylin, processes for their preparation, agents containing them and their use. $ A Compound III and IV $ F1 with (R (1) H, CH ↓ 3 ↓ and R (2) or acyl have excellent...
DE3831465A1 ALKALINE FISSION PRODUCTS AND Elaiophylin ELAIOPHYLINDERIVATEN AND USE THEREOF  
The invention relates to elaiophyl derivatives of the formulas (I), (I '), (III) and (III') $ F1 in which the C = C double bonds in the 2,3- and 4,5-positions may also be hydrogenated and R ↑ 1 ↑,...
DE3831695A1 ELAIOPHYLINDERIVATE, PROCESS FOR PRODUCING THE USE THEREOF AS DRUGS AND MEDICAMENTS CONTAINING THEM  
The invention relates to Elaiophylinderivate of formula I, II and III $ F1 in which the substituents R (1), R (2), R (3) and R (3 ') have the meanings given. The compounds show antibacterial and...
DE3814138A1 ELAIOPHYLINDERIVATE, METHOD FOR THE PRODUCTION AND USE AS MEDICINE  
Elaiophane derivatives, process for their preparation and use as a remedy. Compounds $ F1 with R1 equal to IV and / or V are very effective anthelmintics. They are obtained by cycloaddition of...
DE3727648A1 NEW avermectin DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE  
The present invention relates to novel avermectin derivatives of the formula I $ F1 in which R1 represents hydrogen, OH, C 1-5 alkanoyloxy, α-L-oleandrosyloxy, α-L-oleandrosyl-α-L-oleandrosyloxy,...
DE3826562A1 EPIPODOPHYLLOTOXINGLUCOSID-4 'phosphate DERIVATIVES  
Phosphate derivatives of 4'-Demethylepipodophyllotoxinglucosiden are novel antitumor agents, and their salts have a pharmaceutically advantageous property in their high water solubility.
DE3141970C2 Use of mangiferin for the treatment of herpes  
The present invention relates to the field of medicine. The medicament for the treatment of diseases caused by the virus of the herpes group contains as active ingredient...

Matches 1 - 31 out of 31